| 000 | 01533 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513063451.0 | ||
| 264 | 0 | _c19940601 | |
| 008 | 199406s 0 0 eng d | ||
| 022 | _a1056-8727 | ||
| 024 | 7 |
_a10.1016/1056-8727(94)90006-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDvornik, D | |
| 245 | 0 | 0 |
_aTolrestat pharmacokinetics in rat peripheral nerve. _h[electronic resource] |
| 260 |
_bJournal of diabetes and its complications _c |
||
| 300 |
_a18-26 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 |
_aAldehyde Reductase _xantagonists & inhibitors |
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aGalactitol _xmetabolism |
| 650 | 0 | 4 |
_aGalactose _xmetabolism |
| 650 | 0 | 4 |
_aGalactosemias _xmetabolism |
| 650 | 0 | 4 |
_aGlucose _xmetabolism |
| 650 | 0 | 4 | _aHalf-Life |
| 650 | 0 | 4 |
_aInositol _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMetabolic Clearance Rate |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNaphthalenes _xadministration & dosage |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aSciatic Nerve _xdrug effects |
| 650 | 0 | 4 | _aSpecies Specificity |
| 700 | 1 | _aMillen, J | |
| 700 | 1 | _aHicks, D R | |
| 700 | 1 | _aKraml, M | |
| 773 | 0 |
_tJournal of diabetes and its complications _gvol. 8 _gno. 1 _gp. 18-26 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/1056-8727(94)90006-x _zAvailable from publisher's website |
| 999 |
_c8166700 _d8166700 |
||